Edward Burns, M.D., executive dean, presents opening remarks at "Licensing Einstein Technology: The Inside Story: Metastatic Melanoma & Pain Therapeutics." Presenters and panelists describe the path of a novel melanoma technology invented at Einstein — from its beginnings in the lab to its current stage in clinical trials sponsored by Pain Therapeutics, Inc. (September 24, 2009)